Internal Medicine, Infectious Disease · Altamonte Springs, FL
NPI
1831272061
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
685 Palm Springs Dr, Suite 2a
Altamonte Springs, FL, 32701
Phone (407) 830-5577
Groups this clinician bills Medicare through
Medicare paid, 2024
$182K
21,860 services
Medicare patients, 2024
419
Average age 69
Drug cost, 2024
$269K
591 prescriptions
Company payments, 2025
$148K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan D Diaz was code 99232 (hospital e&m - subsequent), 1,282 times for 301 patients. In total Juan D Diaz billed 21,860 services in 26 codes, and Medicare paid $182K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,282 | 301 | $60.72 | $78K |
| 99233 Hospital E&M - Subsequent | Facility | 421 | 123 | $92.17 | $39K |
| 99222 Hospital E&M - Initial | Facility | 175 | 166 | $100.96 | $18K |
| 99214 Office E&M - Established | Office | 168 | 78 | $97.67 | $16K |
| 99223 Hospital E&M - Initial | Facility | 58 | 49 | $134.03 | $7,774 |
| 99231 Hospital E&M - Subsequent | Facility | 54 | 28 | $38.74 | $2,092 |
| 96365 Intravenous Infusion, Hydration | Office | 51 | 12 | $46.79 | $2,387 |
| 99204 Office E&M - New | Office | 17 | 17 | $127.92 | $2,175 |
By year: 2022 $167K for 8,456 services; 2023 $235K for 12,277 services; 2024 $182K for 21,860 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juan D Diaz prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 67 prescriptions and refills. In total Juan D Diaz wrote 591 Medicare prescriptions that cost $269K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 67 | 67 | 13 | $9,800 |
| Cefuroxime Cefuroxime Axetil | 57 | 59 | 39 | $1,775 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 40 | 40 | 29 | $562 |
| Cefdinir Generic | 30 | 34 | 24 | $871 |
| Levofloxacin Generic | 28 | 29 | 25 | $154 |
| Ciprofloxacin Hcl Generic | 28 | 28 | 21 | $248 |
| Meropenem Generic | 23 | 23 | 14 | $5,266 |
| Ertapenem Ertapenem Sodium | 20 | 20 | 11 | $10K |
| Acyclovir Generic | 19 | 23 | Under 11 | $276 |
| Valganciclovir Hcl Generic | 19 | 19 | Under 11 | $4,944 |
| Daptomycin Generic | 17 | 17 | Under 11 | $35K |
| Cefepime Hcl Generic | 14 | 14 | Under 11 | $3,884 |
| Micafungin Micafungin Sodium | 14 | 14 | Under 11 | $16K |
| Doxycycline Hyclate Generic | 13 | 13 | 13 | $72.91 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 12 | 12 | Under 11 | $3,134 |
Brand drugs: 55 claims; generic drugs: 536 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan D Diaz $148K ($148K in general payments such as food, travel and fees) from 11 companies. The largest payer was Merck Sharp & Dohme LLC with $39K.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 38 | $39K |
| Melinta Therapeutics, LLC | 63 | $30K |
| Shionogi Inc 4507.T | 29 | $28K |
| Abbvie Inc. ABBV | 35 | $23K |
| La Jolla Pharmaceutical Company | 24 | $20K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 13 | $7,824 |
| Astellas Pharma US Inc 4503.T | 6 | $344 |
| Insmed, Inc. INSM | 15 | $195 |
| Tetraphase Pharmaceuticals, Inc. | 7 | $131 |
| Aimmune Therapeutics, Inc. | 3 | $88.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.